As commercial and clinical teams plan strategies for differentiation and success, they rely on the series for up-to-date, data-driven insights, across 20 immunology indications.
Have confidence that you understand the implications of the changing landscape in the immunology space and you are equipped with the knowledge to inform clinical investment decisions.
Diseases covered in the series
Acute Graft versus Host Disease (aGvHD)
Nonalcoholic Steatohepatitis (NASH)
Sickle Cell Disease
Systemic Lupus Erythematosus
Senior Commercial and Strategy Director
Brendan has over 20 years’ of progressive experience serving as a partner to stakeholders in life sciences, pharmaceutical, biotech and healthcare. His research experience spans all facets of qualitative and quantitative primary market research, competitive intelligence, secondary and syndicated research.